Muzzey Dale 4

What Happened Dale Muzzey, Chief Scientific Officer of Myriad Genetics (MYGN), had 2,019 shares of common stock withheld by the company on March 22, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. The withholding was recorded at $4.58 per share for a total value of $9,247. This is a tax-withholding disposition (routine) rather than an open-market sale or a purchase.

Key Details

• Transaction date and price: March 22, 2026 at $4.58 per share.
• Shares withheld/disposed: 2,019 shares; total value $9,247.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Withheld shares were determined based on Myriad’s closing price on March 20, 2026 (see footnote F1).
• Filing date: March 23, 2026 (filed the next day—within the typical Form 4 reporting window).

Context This transaction is a routine tax-withholding event tied to RSU vesting (transaction code F). Such withholdings are common and do not necessarily indicate the insider's view on the company’s prospects; they simply satisfy tax liabilities arising from awards.